Conceptual issues in measuring the burden of skin diseases

Journal of Investigative Dermatology Symposium Proceedings

Volumn 9, Issue 2, 2004, Pages 97-100

  Chren, Mary Margaret ^a,b,e   Weinstock, Martin A ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BROWN UNIVERSITY   (United States)

^d BROWN UNIVERSITY   (United States)

^e SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECONOMIC ASPECT; EDITORIAL; FUNCTIONAL ASSESSMENT; HEALTH CARE COST; HUMAN; INCIDENCE; MEDICAL RESEARCH; METHODOLOGY; MORTALITY; PATIENT MONITORING; QUALITY OF LIFE; SKIN DISEASE; SOCIAL PSYCHOLOGY; TAXONOMY; WELLBEING;

EID: 1842555405     PISSN: 10870024     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1087-0024.2004.09119.x     Document Type: Article

References (20)

1. Chren MM: Giving "scale" new meaning in dermatology: Measurement matters [editorial; comment]. Arch Dermatol 136:786-790, 2000
2. Cohen J: The Global Burden of Disease Study: A useful projection of future global health? J Public Health Med 22:518-524, 2000
3. Feinstein AR: Clinimetrics. New Haven: Yale University Press, 1987
4. Giesler RB, Ashton CM, Brody B, et al: Assessing the performance of utility techniques in the absence of a gold standard. Med Care 37:580-588, 1999
5. Gold MR, Muennig P: Measure-dependent variation in burden of disease estimates: Implications for policy. Med Care 40:260-263, 2002
6. Gross CP, Anderson GF, Powe NR: The relation between funding by the National Institutes of Health and the burden of disease. N Engl J Med 340:1881-1887, 1999
7. Kemp AS: Atopic eczema: Its social and financial costs. J Paediatr Child Health 35:229-231, 1999
8. Lawson V, Lewis-Jones MS, Finlay AY, Reid P, Owens RG: The family impact of childhood atopic dermatitis: The Dermatitis Family Impact Questionnaire. Br J Dermatol 138:107-113, 1998
9. Murray CJ, Lopez AD: Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349:1436-1442, 1997
10. Nease RF Jr, Kneeland T, O'Connor GT, et al: Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. JAMA 273:1185-1190, 1995
11. Nichol G, Llewellyn-Thomas HA, Thiel EC, Naylor CD: The relationship between cardiac functional capacity and patients' symptom-specific utilities for angina: Some findings and methodologic lessons. Med Decis Making 16:78-85, 1996
12. Nygaard E: Is it feasible or desirable to measure burdens of disease as a single number? Reprod Health Matters 8:117-125, 2000
13. Parkerson GR Jr, Broadhead WE, Tse CK: Quality of life and functional health of primary care patients. J Clin Epidemiol 45:1303-1313, 1992
14. Patrick DL: Toward an epidemiology of disablement. Am J Public Health 84:1723-1725, 1994
15. Rice DP, Hodgson TA, Kopstein AN: The economic costs of illness: A replication and update. Health Care Financ Rev 7:61-80, 1985
16. Smith R: In search of "non-disease". Brit Med J 324:883-885, 2002
17. Su JC, Kemp AS, Varigos GA, Nolan TM: Atopic eczema: Its impact on the family and financial cost. Arch Dis Child 76:159-162, 1997
18. Weinstock MA: Epidemiology of melanoma. In: Nathanson I ed Current Research and Clinical Management of Melanoma. Boston: Kluwer Academic, p 29-56, 1993
19. Weinstock MA, Bogaars HA, Ashley M, Litle V, Bilodeau E, Kimmel S: Inaccuracies in certification of nonmelanoma skin cancer deaths. Am J Public Health 82:278-281, 1992
20. th ed. New York: McGraw-Hill, p 4-10, 2003